Company Overview
About Evozyne
Evozyne is a Chicago-based biotechnology company founded in 2020 by Andrew Ferguson and Rama Ranganathan that uses generative AI to design novel, high-performance proteins for therapeutic and commercial applications. The company occupies a distinctive position at the frontier of AI-driven drug discovery: unlike companies that apply AI to screen existing molecule libraries or predict protein folding (like AlphaFold), Evozyne generates entirely new protein sequences from scratch using its proprietary understanding of evolutionary sequence-function relationships. These de novo proteins are designed with specific functional properties for therapeutic development or industrial applications.
Business Model & Competitive Advantage
Evozyne has raised $144M in total funding across four rounds. Its $81M Series B was led by Fidelity Management & Research Company and OrbiMed, with participation from NVentures (NVIDIA''s venture arm) — a significant endorsement given NVIDIA''s central role in AI computing infrastructure. The company has approximately 54 employees and is led by CEO Marc Yoskowitz, who joined from Tempus AI. Evozyne''s platform combines machine learning models trained on evolutionary protein sequence data with high-throughput gene synthesis and laboratory screening to iteratively design and validate protein candidates.
Competitive Landscape 2025–2026
Evozyne''s primary focus areas include therapeutic protein design — targeting diseases where novel protein biologics could offer better efficacy or tolerability than existing treatments — and environmental sustainability applications such as designing enzymes for industrial processes. The company is one of a small cohort of AI-native biotechs advancing de novo therapeutic proteins toward clinical evaluation. It competes with Profluent, Generate Biomedicines, and David Baker''s laboratory spinouts, as well as larger AI drug discovery players like Recursion Pharmaceuticals and Insilico Medicine, though Evozyne''s generative protein design approach is more foundational than conventional AI-for-drug-discovery methods.
Key Differentiators
Emerging Innovator
Evozyne is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Compare Evozyne with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Evozyne? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Evozyne Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Evozyne vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →